Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer

May 29, 2014

MacroGenics and Takeda Pharmaceutical enter into option agreement for MGD-010

May 29, 2014

Roche licenses rights to antibody engineering technologies from Chugai

May 29, 2014

Bristol-Myers Squibb and CytomX Therapeutics establish immune-oncology collaboration

May 29, 2014

Viking Therapeutics licenses five programs from Ligand Pharmaceuticals

May 27, 2014

BioRestorative Therapies signs research agreement with Pfizer

May 27, 2014

Neurotez and GCA Therapeutics sign Chinese license agreement for leptin derivatives

May 23, 2014

Sanford-Burnham and Daiichi Sankyo collaborate in cardiovascular-metabolic diseases

May 23, 2014

Avipero and Fusion Antibodies collaborate to humanize integrin antibodies

May 23, 2014

Gedeon Richter to buy majority stake in marketing company Mediplus

May 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...